Answers are grounded in this paper and cite their sources.
Paromomycin analogue activity: Novel amphiphilic aminoglycosides are shown to inhibit clinically relevant deactivating enzymes, without undergoing significant deactivation themselves.
No takes yet. Share an insight, caveat, or question.
Szychowski et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: